JP2008531719A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008531719A5 JP2008531719A5 JP2007558223A JP2007558223A JP2008531719A5 JP 2008531719 A5 JP2008531719 A5 JP 2008531719A5 JP 2007558223 A JP2007558223 A JP 2007558223A JP 2007558223 A JP2007558223 A JP 2007558223A JP 2008531719 A5 JP2008531719 A5 JP 2008531719A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- antibody
- seq
- amino acids
- fragment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US65778905P | 2005-03-02 | 2005-03-02 | |
| PCT/US2006/007441 WO2006094134A2 (en) | 2005-03-02 | 2006-03-02 | Kim-1 antibodies for treatment of th2-mediated conditions |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012073852A Division JP2012131825A (ja) | 2005-03-02 | 2012-03-28 | Ｔｈ２介在性状態の治療のためのＫＩＭ−１抗体 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008531719A JP2008531719A (ja) | 2008-08-14 |
| JP2008531719A5 true JP2008531719A5 (https=) | 2009-03-26 |
Family
ID=36648475
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007558223A Withdrawn JP2008531719A (ja) | 2005-03-02 | 2006-03-02 | Ｔｈ２介在性状態の治療のためのＫＩＭ−１抗体 |
| JP2012073852A Pending JP2012131825A (ja) | 2005-03-02 | 2012-03-28 | Ｔｈ２介在性状態の治療のためのＫＩＭ−１抗体 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012073852A Pending JP2012131825A (ja) | 2005-03-02 | 2012-03-28 | Ｔｈ２介在性状態の治療のためのＫＩＭ−１抗体 |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US8206705B2 (https=) |
| EP (2) | EP2251037B1 (https=) |
| JP (2) | JP2008531719A (https=) |
| KR (1) | KR101213894B1 (https=) |
| CN (2) | CN103751780A (https=) |
| AT (1) | ATE478707T1 (https=) |
| AU (2) | AU2006218489B2 (https=) |
| BR (1) | BRPI0608254A2 (https=) |
| CA (1) | CA2599967C (https=) |
| DE (1) | DE602006016413D1 (https=) |
| IL (1) | IL185653A (https=) |
| NZ (1) | NZ562045A (https=) |
| WO (1) | WO2006094134A2 (https=) |
| ZA (1) | ZA200708372B (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008064031A2 (en) * | 2006-11-13 | 2008-05-29 | Government Of The United States, As Represented Bythe Secretary Of The Department Of Health And Human Services | Potent activation of antigen presenting cells by the hepatitis a virus cellular receptor 1 and its role in the regulation of immune responses |
| JP6152090B2 (ja) | 2011-04-21 | 2017-06-21 | ザ リージェンツ オブ ザ ユニバーシティ オブ コロラド，ア ボディー コーポレイトＴＨＥ ＲＥＧＥＮＴＳ ＯＦ ＴＨＥ ＵＮＩＶＥＲＳＩＴＹ ＯＦ ＣＯＬＯＲＡＤＯ，ａ ｂｏｄｙ ｃｏｒｐｏｒａｔｅ | 視神経脊髄炎を処置するための組成物および方法 |
| CN108472365A (zh) | 2015-10-30 | 2018-08-31 | 艾丽塔生物治疗剂公司 | 用于肿瘤转导的组合物和方法 |
| US10508143B1 (en) | 2015-10-30 | 2019-12-17 | Aleta Biotherapeutics Inc. | Compositions and methods for treatment of cancer |
Family Cites Families (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5179017A (en) | 1980-02-25 | 1993-01-12 | The Trustees Of Columbia University In The City Of New York | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
| US4399216A (en) | 1980-02-25 | 1983-08-16 | The Trustees Of Columbia University | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
| US4634665A (en) | 1980-02-25 | 1987-01-06 | The Trustees Of Columbia University In The City Of New York | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
| GB8607679D0 (en) | 1986-03-27 | 1986-04-30 | Winter G P | Recombinant dna product |
| JP3101690B2 (ja) | 1987-03-18 | 2000-10-23 | エス・ビィ・２・インコーポレイテッド | 変性抗体の、または変性抗体に関する改良 |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| IL162181A (en) | 1988-12-28 | 2006-04-10 | Pdl Biopharma Inc | A method of producing humanized immunoglubulin, and polynucleotides encoding the same |
| US5789650A (en) | 1990-08-29 | 1998-08-04 | Genpharm International, Inc. | Transgenic non-human animals for producing heterologous antibodies |
| EP1400536A1 (en) | 1991-06-14 | 2004-03-24 | Genentech Inc. | Method for making humanized antibodies |
| DE69419721T2 (de) | 1993-01-12 | 2000-04-27 | Biogen, Inc. | Rekombinante anti-vla4 antikörpermoleküle |
| US5827690A (en) | 1993-12-20 | 1998-10-27 | Genzyme Transgenics Corporatiion | Transgenic production of antibodies in milk |
| US5622861A (en) | 1994-08-05 | 1997-04-22 | The United States Of America As Represented By The Department Of Health And Human Services | Recombinant DNA encoding hepatitis A virus receptor |
| US6066322A (en) | 1995-03-03 | 2000-05-23 | Millennium Pharmaceuticals, Inc. | Methods for the treatment of immune disorders |
| WO1996034096A1 (en) | 1995-04-28 | 1996-10-31 | Abgenix, Inc. | Human antibodies derived from immunized xenomice |
| DE19541844C1 (de) | 1995-11-09 | 1997-07-24 | Gsf Forschungszentrum Umwelt | Verfahren zur Herstellung von menschlichen Antikörpern und deren Verwendung |
| US6165733A (en) | 1996-05-23 | 2000-12-26 | Chiron Corporation | γ II adaptin |
| ES2258793T5 (es) | 1996-05-24 | 2010-01-25 | Biogen Idec Ma Inc. | Moduladores de la regeneracion tisular. |
| EP0948597A4 (en) | 1996-11-01 | 2002-07-10 | Human Genome Sciences Inc | Human, mucous membrane-specific addressin cell adhesion molecule (MAdCAM-1) and its splice variants |
| CA2722378C (en) | 1996-12-03 | 2015-02-03 | Amgen Fremont Inc. | Human antibodies that bind tnf.alpha. |
| ATE346085T1 (de) | 1996-12-06 | 2006-12-15 | Vertex Pharma | Inhibitoren des interleukin-1-beta konvertierenden enzyms |
| CN101274962A (zh) | 1998-01-23 | 2008-10-01 | 霍夫曼-拉罗奇有限公司 | 人il-12抗体 |
| US6528514B1 (en) | 1998-03-11 | 2003-03-04 | Welfide Corporation | IgE antibody production inhibitors and autoimmune diseases inhibitors |
| US6228642B1 (en) | 1998-10-05 | 2001-05-08 | Isis Pharmaceuticals, Inc. | Antisense oligonucleotide modulation of tumor necrosis factor-(α) (TNF-α) expression |
| US8288322B2 (en) | 2000-04-17 | 2012-10-16 | Dyax Corp. | Methods of constructing libraries comprising displayed and/or expressed members of a diverse family of peptides, polypeptides or proteins and the novel libraries |
| ATE425249T1 (de) | 2000-06-16 | 2009-03-15 | Biogen Idec Inc | Renale regulatorische elemente und deren verwendung |
| DK1401869T3 (da) | 2001-06-01 | 2008-04-28 | Biogen Idec Inc | Molekyler og fremgangsmåder til inhibering af udskillkelse af kim 1 |
| US7838220B2 (en) | 2001-06-29 | 2010-11-23 | The Board Of Trustees Of The Leland Stanford Junior University | T cell regulatory genes associated with immune disease |
| US7553939B2 (en) | 2001-06-29 | 2009-06-30 | The Board Of Trustees Of The Leland Stanford Junior University | T cell regulatory genes and methods of use thereof |
| AU2002330039A1 (en) | 2001-09-17 | 2003-04-01 | Eos Biotechnology, Inc. | Methods of diagnosis of cancer compositions and methods of screening for modulators of cancer |
| WO2003042661A2 (en) | 2001-11-13 | 2003-05-22 | Protein Design Labs, Inc. | Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer |
| US7687454B2 (en) | 2001-12-03 | 2010-03-30 | The University Of British Columbia | Effectors of innate immunity determination |
| US7470428B2 (en) | 2002-01-30 | 2008-12-30 | The Brigham And Women's Hospital, Inc. | Compositions and methods related to TIM-3, a Th1-specific cell surface molecule |
| AU2003228336B2 (en) | 2002-03-19 | 2009-07-30 | Curagen Corporation | Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| GB0215509D0 (en) | 2002-07-04 | 2002-08-14 | Novartis Ag | Marker genes |
| EP2025345A1 (en) * | 2002-12-30 | 2009-02-18 | Biogen Idec MA Inc. | KIM-1 antagonists and use to modulate immune system |
| WO2004084823A2 (en) | 2003-03-19 | 2004-10-07 | Abgenix, Inc. | Antibodies against t cell immunoglobulin domain and mucin domain 1 (tim-1) antigen and uses thereof |
| US20050119210A1 (en) | 2003-05-20 | 2005-06-02 | Xiaobing Be | Compositions and methods for diagnosing and treating cancers |
| TW200539890A (en) | 2004-03-12 | 2005-12-16 | Brigham & Womens Hospital | Methods of modulating immune responses by modulating tim-1, tim-2 and tim-4 function |
| KR20070037570A (ko) | 2004-03-24 | 2007-04-05 | 텔로스 파마슈티칼스 인코포레이티드 | 백신에 대한 면역반응을 향상시키는 보강제로서의 조성물및 이의 사용 방법 |
| US8025557B2 (en) | 2009-02-27 | 2011-09-27 | Illinois Tool Works Inc. | Sanding clay |
-
2006
- 2006-03-02 KR KR1020077022608A patent/KR101213894B1/ko not_active Expired - Fee Related
- 2006-03-02 DE DE602006016413T patent/DE602006016413D1/de not_active Expired - Lifetime
- 2006-03-02 EP EP10173620.5A patent/EP2251037B1/en not_active Expired - Lifetime
- 2006-03-02 US US11/817,638 patent/US8206705B2/en not_active Expired - Fee Related
- 2006-03-02 CN CN201410043208.1A patent/CN103751780A/zh active Pending
- 2006-03-02 CA CA2599967A patent/CA2599967C/en not_active Expired - Fee Related
- 2006-03-02 AU AU2006218489A patent/AU2006218489B2/en not_active Ceased
- 2006-03-02 AT AT06736714T patent/ATE478707T1/de not_active IP Right Cessation
- 2006-03-02 BR BRPI0608254-8A patent/BRPI0608254A2/pt not_active IP Right Cessation
- 2006-03-02 NZ NZ562045A patent/NZ562045A/en not_active IP Right Cessation
- 2006-03-02 JP JP2007558223A patent/JP2008531719A/ja not_active Withdrawn
- 2006-03-02 WO PCT/US2006/007441 patent/WO2006094134A2/en not_active Ceased
- 2006-03-02 CN CNA2006800139893A patent/CN101166542A/zh active Pending
- 2006-03-02 EP EP06736714A patent/EP1865985B1/en not_active Expired - Lifetime
-
2007
- 2007-09-02 IL IL185653A patent/IL185653A/en not_active IP Right Cessation
- 2007-10-01 ZA ZA200708372A patent/ZA200708372B/xx unknown
-
2011
- 2011-05-24 AU AU2011202405A patent/AU2011202405B2/en not_active Ceased
-
2012
- 2012-03-28 JP JP2012073852A patent/JP2012131825A/ja active Pending
- 2012-04-04 US US13/439,413 patent/US20130089539A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009511480A5 (https=) | ||
| JP2024075713A5 (https=) | ||
| FI3569620T3 (fi) | Ihmisen cgrp-reseptoria sitovat vasta-aineet | |
| JP2013518912A5 (https=) | ||
| JP2021038246A (ja) | 分泌様免疫グロブリンを含む組成物 | |
| JP2010512320A5 (https=) | ||
| JP2006506333A5 (https=) | ||
| JP2023081303A5 (https=) | ||
| JP2020536109A5 (https=) | ||
| JP2009539841A5 (https=) | ||
| NO20051048L (no) | Terapeutisk humant anti-IL-1R1 monoklonalt antistoff | |
| JP2006522830A5 (https=) | ||
| JP2006519762A5 (https=) | ||
| JP2010526028A5 (https=) | ||
| RU2012141556A (ru) | Способы и композиции для лечения болезни дего | |
| HRP20190008T4 (hr) | Prevencija i liječenje sinukleinopatske i amiloidogene bolesti | |
| US20160002343A1 (en) | Blood-brain barrier (bbb) penetrating dual specific binding proteins for treating brain and neurological diseases | |
| JP2012121878A5 (https=) | ||
| JP2020506162A (ja) | 抗ａｐｏｅ抗体 | |
| JP2011502137A5 (https=) | ||
| JP2016509585A5 (https=) | ||
| JP2011207882A5 (https=) | ||
| JP2017113019A5 (https=) | ||
| JP2021524231A5 (https=) | ||
| JP2005505256A5 (https=) |